Hospital Universitario Nuestra Señora de Candelaria -ko ikertzaileekin lankidetzan egindako argitalpenak (49)

2024

  1. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

    Microchemical Journal, Vol. 199

  2. Oxygen therapy could improve survival in patients with early desaturation in the 6-minute walk test: A post hoc analysis

    Respirology

  3. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. A Novel Figure and Algorithm for the GOLD-ABE Classification: Additional Comments

    Archivos de Bronconeumologia

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  4. Change in physical activity related to admission for exacerbation in COPD patients

    Respiratory Medicine, Vol. 212

  5. Development and validation of a prognostic index (BODEXS90) for mortality in stable chronic obstructive pulmonary disease

    Pulmonology, Vol. 29, Núm. 4, pp. 276-283

  6. Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD

    Lung, Vol. 201, Núm. 2, pp. 217-224

  7. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  8. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  9. Physical activity and sedentary behaviour in patients admitted with COPD: Associated factors

    Respiratory Medicine and Research, Vol. 84

  10. SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge

    Pediatric Pulmonology, Vol. 58, Núm. 11, pp. 3195-3205

2022

  1. Evaluation of the multimorbidity network and its relationship with clinical phenotypes in chronic obstructive pulmonary disease: The GALAXIA study

    Clinical Respiratory Journal, Vol. 16, Núm. 7, pp. 504-512

  2. Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events

    Archivos de Bronconeumologia, Vol. 58, Núm. 5, pp. 451-453

  3. The 7 Cardinal Sins of COPD in Spain

    Archivos de Bronconeumologia

  4. Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality Risk

    Lung, Vol. 200, Núm. 5, pp. 601-607

2021

  1. Discordance in treatment of chronic obstructive pulmonary disease following GesEPOC Guideline vs. GOLD

    Revista Clinica Espanola, Vol. 221, Núm. 9, pp. 536-539

  2. Forum COPD Working Group Consensus on the Diagnosis, Treatment and Follow-Up of COPD

    Archivos de Bronconeumologia, Vol. 57, Núm. 9, pp. 596-599

  3. Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria with GOLD 2021?

    Archivos de Bronconeumologia